AI assistant
Sending…
Coloplast — Director's Dealing 2012
Dec 28, 2012
3358_rpt_2012-12-28_b43b5ff7-ba10-44b5-9535-83df2f098b6a.pdf
Director's Dealing
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
NASDAQ OMX Nordic 28 December 2012
Coloplast A/S Holtedam 1 DK-3050 Humlebæk Denmark Tel: +45 4911 1111 www.coloplast.com CVR No. 69749917
Report on transactions of executives and related parties in Coloplast shares and related securities
According to the Danish Securities Act § 28a Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.
| Name | Lars Rasmussen | Lene Skole |
|---|---|---|
| Reason | Executive Management | Executive Management |
| Issuer | Coloplast A/S | Coloplast A/S |
| ISIN code | DK0010309657 | DK0010309657 |
| Description | Shares | Shares |
| Transaction | Receipt of shares as a flexible benefit (The Danish Tax Assessment Act §7A) |
Receipt of shares as a flexible benefit (The Danish Tax Assessment Act §7A) |
| Trade date | 28 December 2012 | 28 December 2012 |
| Market | NASDAQ OMX Nordic | NASDAQ OMX Nordic |
| Number | 145 | 145 |
| Share price in DKK | 156.69 | 156.69 |
| Market value in DKK | 22,720.34 | 22,720.34 |
Kind regards, Coloplast A/S
Gunilla Jensen
This information is available in Danish and in English, in case of doubt the Danish version prevails.
For further information: Gunilla Jensen, tel. +45 49 11 18 00.
Gunilla Jensen IR coordinator
Dir. tel. +45 49 11 18 00 Mobile +45 49 11 36 21 Fax +45 49 11 15 55 [email protected]
More from Coloplast
Earnings Release
2026
Apr 23
Earnings Release
2026
Apr 23
Earnings Release
2026
Apr 23
Earnings Release
2026
Apr 23
Director's Dealing
2026
Mar 12
Director's Dealing
2026
Mar 12
Director's Dealing
2026
Mar 12
Director's Dealing
2026
Mar 12
Director's Dealing
2026
Mar 11
Director's Dealing
2026
Mar 11